Advanced Nano-Based Controlled Drug Release Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 193
Special Issue Editors
Interests: targeted drug delivery; nanomaterials; antibody–drug conjugates
Interests: cancer diagnosis and therapy; development of fluorescence based molecular sensors for reactive species; theranostic probe development for cancer diagnosis and therapy; total organic synthesis of natural products; synthesis of various medicinal chemistry related organic molecules
Interests: drug delivery; lipid nanocarriers; polymeric nanocarriers; liposomal drug delivery systems; exosome-based drug delivery systems
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Our journal seeks manuscript submissions for a Special Issue on "Advanced Nano-Based Controlled Drug Release Systems". Nano-based drug delivery has revolutionized therapy, optimizing outcomes and care. Harnessing nanomaterial properties, such as liposomes, nanoparticles, polymeric micelles, hydrogels, and dendrimers, these systems precisely control therapeutic agent release for enhanced efficacy, safety, and bioavailability. Manuscripts addressing key challenges; innovative strategies; and system design, synthesis, characterization, and evaluation are welcome.
You may submit original research, reviews, or critical perspectives on fundamental principles, novel techniques, and applications of advanced nano-based controlled drug release systems. Emphasis could be on mechanisms, optimization, clinical translation, and explored applications in diverse fields, including cancer treatment, cardiovascular diseases, infectious diseases, neurological disorders, and regenerative medicine. Your manuscript will contribute to the growing knowledge in this field, reaching a global audience of experts. Join us in advancing drug delivery and improving patient care via the implementation of advanced nano-based controlled drug release systems. We eagerly await your valuable contributions.
Dr. Anil Parsram Bidkar
Dr. Kondapa Naidu Bobba
Dr. Santosh Bashyal
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- advanced drug delivery systems
- controlled drug release
- targeted drug delivery
- nanomaterials
- nano-based drug delivery
